3Mixtatin Versus Modified 3Mix-MP in Lesion Sterilization and Tissue Repair for Treatment of Necrotic Primary Molars
NCT ID: NCT05677945
Last Updated: 2023-01-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
24 participants
INTERVENTIONAL
2023-03-31
2024-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
3Mixstatin ,Tri-Antibiotic Mix & Simvastatin in the Treatment of Primary Molars
NCT03585751
Evaluation of Postoperative Pain After Using 3MIX-TATIN Versus Calcium Hydroxide Iodoform Paste In Necrotic Primary Molars Treated by Lesion Sterilization and Tissue Repair Therapy
NCT03084601
Lesion Sterilization And Tissue Repair Versus Zinc Oxide And Eugenol For Treatment of Necrotic Primary Molars
NCT05448937
Clinical and Radiographic Evaluation of Zinc Oxide-Propolis Mixture Versus Modified Triple Antibiotic Paste in LSTR
NCT06158451
Evaluation of Different Medicaments in the Management of Necrotic Primary Molars by Lesion Sterilization and Tissue Repair
NCT06926322
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In necrotic primary molars with peri-radicular lesions and/or external root, resorption does adding Simvastatin to the triple antibiotic mix have higher clinical and radiographic success than the triple antibiotic paste solely?
Statement of the problem:
Primary teeth with necrotic pulp and extensive root resorption and/or furcal radiolucency are not uncommon scenarios that pediatric dentists are exposed to. Such clinical and radiographic presentations contraindicate the application of conventional pulpectomy treatment. Lesion Sterilization and Tissue Repair (LSTR) is an approach that has shown promising results in maintaining such teeth for up to 12 months. Primary teeth serve as a natural space maintainer, enable normal and healthy functioning of the child, and eliminate the chances for malocclusion and growth pattern disruptions. LSTR offers practitioners a promising option to save those teeth when all other treatment options seem impossible.
The Rationale for Conducting the Research:
In accordance to the popularity that LSTR has recently been gaining in the field of Pediatric dentistry, an abundance of studies have been conducted in the recent years. Researchers are striving to explore the plethora of possibilities and variances in the LSTR technique that could help clinicians practice better and achieve more for their patients. Amongst the alternatives is the recent and common detour towards regenerative dentistry.
Simvastatin, one of the materials, remains of high interest to the field due to its healing powers. However, to our knowledge insufficient studies are available on the direct comparison of the clinical and radiographic success including bone regeneration using the 3Mixtatin versus 3Mix alone. Furthermore, studies conducted warrant the need for further studies directly comparing 3Mixtatin with 3mix. Therefore, this study aims to come to a conclusion on whether the 3mix with the host's body defense and repair mechanism are sufficient to save a necrotic primary tooth or is some help in bone regeneration and healing promotion needed.
The LSTR technique involves non-instrumentation or minimal instrumentation followed by sterilization of the infected pulpal space by the placement of a triple antibiotic mixture in a propylene glycol vehicle to disinfect the microbial flora inhabiting the infected root canal systems and peri-apical lesions. The latter step achieves disinfection while tissue repair is then allowed to take place by the host's natural body defense mechanisms
The triple antibiotic paste (TAP/3mix), is an intracanal medicament that has continuously proven its efficacy and superiority for years against the microflora inhabiting necrotic canals predominantly Enterococcus Faecalis, the most prevalent organism in infected root canals. Metronidazole, ciprofloxacin, and minocycline, the oldest and most common combination suggested by Takushige et al., has been subjected to many studies and changes due to the discoloration caused by minocycline. As a result of, modified triple antibiotic paste (Modified-3mix) was introduced to replace minocycline with clindamycin.
Statins are antihyperlipidemic drugs, with a bio inductive feature that includes inhibition of bone resorption and promotion of osteoblast proliferation and differentiation as well as stimulating angiogenesis all of which aid in the healing process. In a clinical trial mixing modified 3mix with statins in, namely, Simvastatin; resulted in excellent clinical and radiographic success rates. Hence, modifying the LSTR technique to include regenerative materials such as statin is an extremely promising area of research.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
When a patient agrees to participate in the trial, an envelope will be drawn by one of the residents present at the clinic and name, telephone number and patient's I.D. will be written on it. Those selected envelops will be opened at treatment visit after performing access cavity to choose which material should be used. Randomization and allocation concealment will be performed by the co-supervisor to avoid selection bias. The participant will not be aware of which treatment modality he will be receiving.
Principal investigator will not be blinded due to differences in preparation of the mix.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
(Group I Experimental Group):Simvastatin mixed with modified triple antibiotic (3Mixtatin)
Patients will then be allocated into either one of the groups alternatively after access cavity preparation depending on the mix to be used as follows:
for this group:
* 2mg of pure Simvastatin powder will be added to the 1:1:1 3Mix powder and will be stored together in an air tight porcelain container to avoid the exposure to moisture and light.
* Upon clinical application the 3Mixtatin powder will be mixed with normal saline to form a paste and is then applied in the same manner as the Modified 3Mix-MP paste.
3Mixtatin paste: Simvastatin mixed with modified triple antibiotic
* Drying the mucosa with gauze,topical anesthesia will be applied.
* Administration of local anesthesia with vasoconstrictor.
* Rubber dam isolation.
* Caries removal \& access cavity using a round bur mounted on a high-speed contra with coolant.
* Removal of necrotic pulp tissue in coronal portion of the tooth using sharp excavator.
* Radicular section will be kept untouched,no instrumentation.
* Using disposable syringe Irrigation of the pulp chamber with 2.5% NaOCl.
* In case of hemorrhage moist cotton immersed in 1% NaOCL will be placed to achieve hemostasis.
* Drying the access cavity with sterile cotton pellets.
* Freshly mixed 3Mix-MP or 3Mixtatin paste (according to group of intervention) will be transferred to the floor of the pulp chamber using an amalgam carrier \& condensed over orifices using a moist cotton pellet.
* Cavity sealing with RMGI capsules.
* Same visit placement with preformed Stainless-steel crown(3M® ESPE)cemented with glass ionomer cement.
Group II Control group Modified triple antibiotic mix in propylene glycol (3Mix)
* Removal of enteric coating/capsule of the three antibiotic tablets using a surgical blade.
* 500 mg Metronidazole tab
* 500 mg Ciprofloxacin tab
* 200 mg Cefixime caps
* Pulverization of each of the drug, will be done using a pestle \& mortar, stored in an air tight porcelain container to avoid the exposure to moisture \& light.
* Pulverized powders will be stored at a temperature of 16°C.Powder should be allowed to be cooled to the room temperature before initiating the preparation of 3Mix-MP paste.
* Powders will be mixed in the proportion of: 1:1:1 by volume (Hoshino et al., 1988).
* Vehicle that will be used is Systane eye drops (Kharadly et al., 2022) it contains the two main components propylene Glycol (Macrogol) \& polyethylene glycol.
* The prepared antibiotic powder is mixed with the prepared vehicle in the ratio of 7:1 by volume. The two steps above are done after access cavity preparation to obtain a fresh mix.
3Mix: Modified triple antibiotic mix in propylene glycol
* Drying the mucosa with gauze,topical anesthesia will be applied.
* Administration of local anesthesia with vasoconstrictor.
* Rubber dam isolation.
* Caries removal \& access cavity using a round bur mounted on a high-speed contra with coolant.
* Removal of necrotic pulp tissue in coronal portion of the tooth using sharp excavator.
* Radicular section will be kept untouched,no instrumentation.
* Using disposable syringe Irrigation of the pulp chamber with 2.5% NaOCl.
* In case of hemorrhage moist cotton immersed in 1% NaOCL will be placed to achieve hemostasis.
* Drying the access cavity with sterile cotton pellets.
* Freshly mixed 3Mix-MP or 3Mixtatin paste (according to group of intervention) will be transferred to the floor of the pulp chamber using an amalgam carrier \& condensed over orifices using a moist cotton pellet.
* Cavity sealing with RMGI capsules.
* Same visit placement with preformed Stainless-steel crown(3M® ESPE)cemented with glass ionomer cement.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
3Mixtatin paste: Simvastatin mixed with modified triple antibiotic
* Drying the mucosa with gauze,topical anesthesia will be applied.
* Administration of local anesthesia with vasoconstrictor.
* Rubber dam isolation.
* Caries removal \& access cavity using a round bur mounted on a high-speed contra with coolant.
* Removal of necrotic pulp tissue in coronal portion of the tooth using sharp excavator.
* Radicular section will be kept untouched,no instrumentation.
* Using disposable syringe Irrigation of the pulp chamber with 2.5% NaOCl.
* In case of hemorrhage moist cotton immersed in 1% NaOCL will be placed to achieve hemostasis.
* Drying the access cavity with sterile cotton pellets.
* Freshly mixed 3Mix-MP or 3Mixtatin paste (according to group of intervention) will be transferred to the floor of the pulp chamber using an amalgam carrier \& condensed over orifices using a moist cotton pellet.
* Cavity sealing with RMGI capsules.
* Same visit placement with preformed Stainless-steel crown(3M® ESPE)cemented with glass ionomer cement.
3Mix: Modified triple antibiotic mix in propylene glycol
* Drying the mucosa with gauze,topical anesthesia will be applied.
* Administration of local anesthesia with vasoconstrictor.
* Rubber dam isolation.
* Caries removal \& access cavity using a round bur mounted on a high-speed contra with coolant.
* Removal of necrotic pulp tissue in coronal portion of the tooth using sharp excavator.
* Radicular section will be kept untouched,no instrumentation.
* Using disposable syringe Irrigation of the pulp chamber with 2.5% NaOCl.
* In case of hemorrhage moist cotton immersed in 1% NaOCL will be placed to achieve hemostasis.
* Drying the access cavity with sterile cotton pellets.
* Freshly mixed 3Mix-MP or 3Mixtatin paste (according to group of intervention) will be transferred to the floor of the pulp chamber using an amalgam carrier \& condensed over orifices using a moist cotton pellet.
* Cavity sealing with RMGI capsules.
* Same visit placement with preformed Stainless-steel crown(3M® ESPE)cemented with glass ionomer cement.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Positive parental informed consent.
* Restorable necrotic mandibular second primary molars with peri-radicular/furcal involvement and/or pathologic root resorption (external or internal).
* Presence of chronic apical abscess or sinus tract or furcation radiolucency. (Thakur et al., 2021)
Exclusion Criteria
* Children with known allergy to any of the components being utilized.
* Molars near exfoliation.
* Molars with severely resorbed roots more than two thirds indicated for extraction
* Molars with insufficient coronal structure disabling proper coronal seal.
* Presence of periapical or interradicular radiolucent area which could compromise the permanent tooth bud. (Shetty et al., 2020)
4 Years
7 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dalia Magdy Abdel Azeem Al Shamy
Masters Student
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rania Nasr, Professor
Role: STUDY_DIRECTOR
Professor of pediatric dentistry
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Maii Mohamed, lecturer
Role: CONTACT
References
Explore related publications, articles, or registry entries linked to this study.
Chak RK, Singh RK, Mutyala J, Killi NK. Clinical Radiographic Evaluation of 3Mixtatin and MTA in Primary Teeth Pulpotomies: A Randomized Controlled. Int J Clin Pediatr Dent. 2022;15(Suppl 1):S80-S86. doi: 10.5005/jp-journals-10005-2216.
Hoshino E, Kurihara-Ando N, Sato I, Uematsu H, Sato M, Kota K, Iwaku M. In-vitro antibacterial susceptibility of bacteria taken from infected root dentine to a mixture of ciprofloxacin, metronidazole and minocycline. Int Endod J. 1996 Mar;29(2):125-30. doi: 10.1111/j.1365-2591.1996.tb01173.x.
Hoshino E, Kota K, Sato M, Iwaku M. Bactericidal efficacy of metronidazole against bacteria of human carious dentin in vitro. Caries Res. 1988;22(5):280-2. doi: 10.1159/000261121.
Aminabadi NA, Huang B, Samiei M, Agheli S, Jamali Z, Shirazi S. A Randomized Trial Using 3Mixtatin Compared to MTA in Primary Molars with Inflammatory Root Resorption: A Novel Endodontic Biomaterial. J Clin Pediatr Dent. 2016;40(2):95-102. doi: 10.17796/1053-4628-40.2.95.
Sain S, J R, S A, George S, S Issac J, A John S. Lesion Sterilization and Tissue Repair-Current Concepts and Practices. Int J Clin Pediatr Dent. 2018 Sep-Oct;11(5):446-450. doi: 10.5005/jp-journals-10005-1555. Epub 2018 Oct 1.
Takushige T, Cruz EV, Asgor Moral A, Hoshino E. Endodontic treatment of primary teeth using a combination of antibacterial drugs. Int Endod J. 2004 Feb;37(2):132-8. doi: 10.1111/j.0143-2885.2004.00771.x.
Thakur S, Deep A, Singhal P, Chauhan D. A randomized control trial comparing the efficacy of 3Mixtatin and Modified 3Mix-MP paste using lesion sterilization and tissue repair technique to conventional root canal treatment in primary molars of children aged 4-8 years: An in vivo study. Dent Res J (Isfahan). 2021 Nov 22;18:93. doi: 10.4103/1735-3327.330874. eCollection 2021.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LSTR in necrotic primary teeth
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.